Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CanSino Biologics Inc.
  6. News
  7. Summary
    6185   CNE100003F01

CANSINO BIOLOGICS INC.

(6185)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CanSino Biologics : ANNOUNCEMENT CHANGE OF VENUE OF THE 2021 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON JULY 30, 2021

07/29/2021 | 08:29am EDT

Pursuant to the Codes on Takeovers and Mergers and Share Repurchases ('Takeovers Codes'), a copy of each document to be displayed under Note 1 to Rule 8 of the Takeovers Codes must be provided by the issuer of the offer document or offeree board circular, as appropriate, to Securities and Futures Commission ('SFC') for display on the SFC's website. To access these documents on display, you can either click this link https://www.sfc.hk/dod/jsp/EN/DoDmain.jsp or click the View Documents on Displaybutton next to the subject title of the offer document or offeree board circular.

Some of the files are prepared in the portable document format and viewing them requires Adobe(R) Reader(R) which can be downloaded free of charge.

Disclaimer

Cansino Biologics Inc. published this content on 29 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 July 2021 12:28:06 UTC.


© Publicnow 2021
All news about CANSINO BIOLOGICS INC.
09/10Cansino Biologics Inc. Announces Executive Changes
CI
09/07CANSINO BIOLOGICS : Indonesia approves J&J, Cansino COVID-19 vaccines for emerge..
RE
09/07SINOVAC BIOTECH : Mixing CanSinoBIO, Sinovac COVID shots induces stronger respon..
RE
09/06CORONAVIRUS PANDEMIC : Chinese developer shares efficacy of inhaled vaccines
PU
08/27CANSINO BIOLOGICS : COVID shot drives CanSinoBIO's first six-month profit since ..
RE
08/27Cansino Biologics Inc. Reports Audited Consolidated Earnings Results for the ..
CI
08/13Certain A Shares of CanSino Biologics Inc. are subject to a Lock-Up Agreement..
CI
08/13CANSINO BIOLOGICS INC.(SHSE : 688185) added to Shanghai Stock Exchange A Share I..
CI
08/13CANSINO BIOLOGICS INC.(SHSE : 688185) added to Shanghai Stock Exchange Composite..
CI
08/06CANSINO BIOLOGICS : CanSinoBIO COVID-19 says booster shot can reverse drop in an..
RE
More news
Analyst Recommendations on CANSINO BIOLOGICS INC.
More recommendations
Financials
Sales 2021 9 984 M 1 544 M 1 544 M
Net income 2021 5 282 M 817 M 817 M
Net cash 2021 5 073 M 785 M 785 M
P/E ratio 2021 11,6x
Yield 2021 0,00%
Capitalization 71 261 M 11 022 M 11 022 M
EV / Sales 2021 6,63x
EV / Sales 2022 2,30x
Nbr of Employees 726
Free-Float 37,1%
Chart CANSINO BIOLOGICS INC.
Duration : Period :
CanSino Biologics Inc. Technical Analysis Chart | 6185 | CNE100003F01 | MarketScreener
Technical analysis trends CANSINO BIOLOGICS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 232,64 CNY
Average target price 308,77 CNY
Spread / Average Target 32,7%
EPS Revisions
Managers and Directors
Xue Feng Yu Chairman, Chief Executive Officer & GM
Jing Wang Chief Financial Officer & Board Secretary
Jiang Feng Li Chairman-Supervisory Board
Tao Zhu Executive Director, CSO & Deputy General Manager
Jun Qiang Li Senior Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CANSINO BIOLOGICS INC.58.64%10 372
CSL LIMITED9.25%102 325
WUXI BIOLOGICS (CAYMAN) INC.19.75%63 410
SAMSUNG BIOLOGICS CO.,LTD.12.95%51 545
BIOGEN INC.22.20%44 664
ALEXION PHARMACEUTICALS, INC.0.00%40 336